Elsevier Logo

Careplan

Pneumonia (Adult, --Obstetrics Inpatient)

Nov.08.2021

Pneumonia (Adult, Obstetrics Inpatient)

Clinical Description

  • Care of the hospitalized patient experiencing an infection of the pulmonary parenchyma that occurs as either a primary disease or as a complication of another condition.

Key Information

  • Knowledge of previous antimicrobial therapy exposure and drug resistance patterns in the patient’s local area may influence choice of empiric antimicrobial therapy (e.g., methicillin, beta-lactam, macrolide).
  • De-escalated (narrowing antibiotic therapy or changing from combination to monotherapy) rather than fixed antibiotic regimens are suggested for patients with hospital-acquired pneumonia and ventilator-associated pneumonia.
  • Viral infection may be present with community-acquired pneumonia. The mortality risk increases when dual bacterial and viral infections are present.
  • Severity scoring tools may assist in predicting mortality from community-acquired pneumonia.

Clinical Goals

By transition of care

A. The patient will achieve the following goals:
  • Fluid Balance

  • Resolution of Infection Signs and Symptoms

  • Effective Oxygenation and Ventilation

B. Patient, family or significant other will teach back or demonstrate education topics and points:
  • Education: Overview
  • Education: Self Management
  • Education: When to Seek Medical Attention

Correlate Health Status

  • Correlate health status to:

    • history, comorbidity
    • age, developmental level
    • sex, gender identity
    • baseline assessment data
    • physiologic status
    • response to medication and interventions
    • psychosocial status, social determinants of health
    • barriers to accessing care and services
    • health literacy
    • cultural and spiritual preferences
    • safety risks
    • family interaction
    • plan for transition of care

Fluid Imbalance

Signs/Symptoms/Presentation: Fluid Deficit

  • capillary refill delayed
  • lightheadedness
  • mental status altered
  • mucous membranes dry
  • muscle weakness
  • postural hypotension
  • skin turgor decreased
  • thirst
  • tongue dry
  • urinary output decreased
  • urine concentration increased

Signs/Symptoms/Presentation: Fluid Excess

  • acute weight gain
  • ascites
  • bounding pulses
  • breath sounds change
  • crackles in lungs
  • edema
  • neck and hand veins distended
  • positive fluid balance
  • restlessness
  • shortness of breath
  • wheezing

Vital Signs

  • heart rate increased or decreased
  • blood pressure increased or decreased

Laboratory Values

  • BUN (blood urea nitrogen) abnormal
  • Hct (hematocrit) abnormal
  • serum sodium abnormal
  • urine specific gravity abnormal

Problem Intervention

Monitor and Manage Fluid Balance

  • Assess fluid requirements to determine fluid therapy strategy.
  • Keep accurate intake, output and daily weight; monitor trends.
  • Monitor laboratory value trends and need for treatment adjustment.
  • Assess need for ongoing intravenous fluid therapy; encourage oral intake when able.
  • Assess neurologic status frequently due to risk of hyponatremia.

Associated Documentation

  • Fluid/Electrolyte Management

Infection

Signs/Symptoms/Presentation

  • appetite change
  • capillary refill delayed
  • chest discomfort
  • chills
  • diaphoresis
  • eating pattern and tolerance change
  • fatigue
  • irritability
  • lethargy
  • listless
  • lymphadenopathy
  • malaise
  • mental status change
  • night sweats
  • pallor
  • peripheral perfusion altered
  • respiratory pattern change
  • restlessness
  • shivering
  • skin cool and moist
  • skin flushed
  • skin mottled
  • skin warm
  • sleepiness
  • urinary output decreased

Vital Signs

  • heart rate increased
  • respiratory rate increased
  • blood pressure increased or decreased
  • SpO2 (peripheral oxygen saturation) decreased
  • body temperature increased or decreased

Laboratory Values

  • ABG (arterial blood gas) abnormal
  • CBC (complete blood count) with differential abnormal
  • blood glucose level abnormal
  • CRP (C-reactive protein) elevated
  • culture positive
  • ESR (erythrocyte sedimentation rate) elevated
  • gram stain positive
  • influenza virus positive
  • PCT (procalcitonin) increased
  • serum lactate elevated

Diagnostic Results

  • CXR (chest x-ray) abnormal
  • chest ultrasound abnormal

Problem Intervention

Prevent Infection Progression

  • Implement transmission-based precautions and isolation, as indicated, to prevent spread of infection.
  • Obtain cultures prior to initiating antimicrobial therapy when possible. Do not delay treatment for laboratory results in the presence of high suspicion or clinical indicators.
  • Administer ordered antimicrobial therapy promptly; reassess need regularly.
  • Monitor laboratory value, diagnostic test and clinical status trends for signs of infection progression.
  • Identify early signs of sepsis, such as increased heart rate and decreased blood pressure, as well as changes in mental state, respiratory pattern or peripheral perfusion.
  • Prepare for rapid sepsis management, including lactate level, intravenous access, fluid administration and oxygen therapy.
  • Provide fever-reduction and comfort measures.

Associated Documentation

  • Fever Reduction/Comfort Measures
  • Infection Management
  • Isolation Precautions

Respiratory Compromise

Signs/Symptoms/Presentation

  • breath sounds abnormal
  • breathing pattern ineffective
  • breathlessness
  • confusion
  • cough impaired
  • cough increased
  • cyanosis
  • irritability
  • restlessness
  • retractions
  • shortness of breath
  • sputum (amount, color or consistency) change
  • swallow function impaired
  • work of breathing increased

Vital Signs

  • heart rate increased
  • respiratory rate increased
  • SpO2 (peripheral oxygen saturation) decreased

Laboratory Values

  • ABG (arterial blood gas) abnormal

Diagnostic Results

  • CXR (chest x-ray) abnormal
  • chest ultrasound abnormal

Problem Intervention

Promote Airway Secretion Clearance

  • Assess the effectiveness of pulmonary hygiene and ability to perform airway clearance techniques.
  • Promote early mobility or ambulation; match activity to ability and tolerance.
  • Encourage deep breathing and lung expansion therapy to prevent atelectasis; adjust treatment to patient’s response.
  • Anticipate the need to splint chest or abdominal wall with cough to minimize discomfort; assist if needed.
  • Initiate cough-enhancement and airway-clearance techniques with instruction.
  • Consider pharmacologic therapy, such as beta-2 agonist, mucolytic, corticosteroid, antimicrobial, that may improve inflammation, mucus clearance, cough response and air flow.

Associated Documentation

  • Breathing Techniques/Airway Clearance
  • Cough And Deep Breathing

Problem Intervention

Optimize Oxygenation and Ventilation

  • Assess and monitor airway, breathing and circulation for effective oxygenation and ventilation; consider oxygenation and ventilation parameters and goal.
  • Maintain head of bed elevation with regular position changes to minimize ventilation-perfusion mismatch and breathlessness; consider prone positioning to maximize alveolar recruitment.
  • Provide oxygen therapy judiciously to avoid hyperoxemia; adjust to achieve oxygenation goal.
  • Monitor fluid balance closely to minimize the risk of fluid overload.
  • Consider positive pressure ventilation to enhance oxygenation and ventilation, as well as reduce work of breathing.

Associated Documentation

  • Airway/Ventilation Management
  • Head of Bed (HOB) Positioning

Education

CPG-Specific Education Topics

Overview

  • description

  • signs/symptoms

Self Management

  • activity

  • fluid/food intake

  • immunizations

  • infection prevention

  • medication management

  • pulmonary hygiene

  • tobacco use, smoke exposure

  • VTE prevention

When to Seek Medical Attention

  • unresolved/worsening symptoms

  • VTE symptoms

General Education Topics

General Education

  • admission, transition of care

  • orientation to care setting, routine

  • advance care planning

  • diagnostic tests/procedures

  • diet modification

  • opioid medication management

  • oral health

  • medication management

  • pain assessment process

  • safe medication disposal

  • tobacco use, smoke exposure

  • treatment plan

Safety Education

  • call light use

  • equipment/home supplies

  • fall prevention

  • harm prevention

  • infection prevention

  • MDRO (multidrug-resistant organism) care

  • personal health information

  • resources for support

Quality Measures

  • NQF 0279 Community-Acquired Pneumonia Admission Rate (PQI 11)

    Admissions with a principal diagnosis of bacterial pneumonia per 1,000 population, ages 18 years and older. Excludes sickle cell or hemoglobin-S admissions, other indications of immunocompromised state admissions, obstetric admissions, and transfers from other institutions.
    Steward: Agency for Healthcare Research and Quality
    Care Setting: Inpatient/Hospital
    National Quality Forum-endorsed measure; CMS188v6
    Last Edited: 03/27/2018

References

  • (2018). Heuer, A. J.; Scanlan, C. L. (Eds.), Wilkins' Clinical Assessment in Respiratory Care. St. Louis: Elsevier. [Core Curriculum]
  • (2018). Heuer, A. J.; Scanlan, C. L. (Eds.), Wilkins' Clinical Assessment in Respiratory Care. St. Louis: Elsevier. [Core Curriculum]
  • (2021). Kacmarek, R. M.; Stoller, J. K.; Heuer, A. J. (Eds.), Egan's Fundamentals of Respiratory Care. St. Louis: Elsevier. [Core Curriculum]
  • (2021). Kacmarek, R. M.; Stoller, J. K.; Heuer, A. J. (Eds.), Egan's Fundamentals of Respiratory Care. St. Louis: Elsevier. [Core Curriculum]
  • Athlin, S.; Lidman, C.; Lundqvist, A.; Naucler, P.; Nilsson, A. C.; Spindler, C.; Strålin, K.; Hedlund, J. Management of community-acquired pneumonia in immunocompetent adults: Updated Swedish guidelines 2017. Infectious Diseases. 2018;50(4), 247-272. doi:10.1080/23744235.2017.1399316 [Quality Measures,Clinical Practice Guidelines]
  • Athlin, S.; Lidman, C.; Lundqvist, A.; Naucler, P.; Nilsson, A. C.; Spindler, C.; Strålin, K.; Hedlund, J. Management of community-acquired pneumonia in immunocompetent adults: Updated Swedish guidelines 2017. Infectious Diseases. 2018;50(4), 247-272. doi:10.1080/23744235.2017.1399316 [Quality Measures,Clinical Practice Guidelines]
  • Athlin, S.; Lidman, C.; Lundqvist, A.; Naucler, P.; Nilsson, A. C.; Spindler, C.; Strålin, K.; Hedlund, J. Management of community-acquired pneumonia in immunocompetent adults: Updated Swedish guidelines 2017. Infectious Diseases. 2018;50(4), 247-272. doi:10.1080/23744235.2017.1399316 [Quality Measures,Clinical Practice Guidelines]
  • Barlam, T. F.; Cosgrove, S. E.; Abbo, L. M.; MacDougall, C.; Schuetz, A. N.; Septimus, E. J.; Srinivasan, A.; Dellit, T. H.; Falack-Ylter, Y. T.; Fishman, N. O.; Hamilton, C. W. Implementing an antibiotic stewardship program: Guidelines by the Infectious Disease Society of American and the Society for Healthcare Epidemiology of America. Clinical Infectious Diseases. 2016;62(10), e51-e77. doi:10.1093/cid/ciw118 Source[Quality Measures,Clinical Practice Guidelines]
  • Barlow, A.; Barlow, B.; Tang, N.; Shah, B. M.; King, A. E. Intravenous fluid management in critically ill adults: A review. Critical Care Nurse. 2020;40(6), e17-e27. doi:10.4037/ccn2020337 [Review Articles]
  • Canada, T. W.; Lord, L. M. (2017). In Fluids, electrolytes, and acid-base disorders. Mueller, C. M (Eds.), The ASPEN adult nutrition support core curriculum. (pp.113-137). Silver Spring, MD: American Society of Parenteral and Enteral Nutrition. [Review Articles,Expert/Committee Opinion,Core Curriculum,Position Statements,Practice Bulletins]
  • Centers for Medicare and Medicaid Services. (2016). NQF 0147. Initial antibiotic selection for community-acquired pneumonia (CAP) in immunocompetent patients. Source[Quality Measures,Clinical Practice Guidelines]
  • Chatwin, M.; Toussaint, M.; Gonçalves, M. R.; Sheers, N.; Mellies, U.; Gonzales-Bermejo, J.; Sancho, J.; Fauroux, B.; Andersen, T.; Hov, B.; Nygren-Bonnier, M.; Lacombe, M.; Pernet, K.; Kampelmacher, M.; Devaux, C.; Kinnett, K.; Sheehan, D.; Rao, F.; Villanova, M.; Berlowitz, D.; Morrow, B. M. Airway clearance techniques in neuromuscular disorders: A state of the art review. Respiratory Medicine. 2018;136, 98-110. doi:10.1016/j.rmed.2018.01.012 [Review Articles,Expert/Committee Opinion,Core Curriculum,Position Statements,Practice Bulletins]
  • Chu, D. K.; Kim, L. H.; Young, P. J.; Zamiri, N.; Almenawer, S. A.; Jaeschke, R.; Szczeklik, W.; Schünemann, H. J.; Neary, J. D.; Alhazzani, W. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): A systematic review and meta-analysis. The Lancet. 2018;391(10131), 1693-1705. doi:10.1016/S0140-6736(18)30479-3 [Metasynthesis,Meta-analysis,Systematic Review]
  • Davidson, A. C.;Banham, S.; Elliott, M.; Kennedy, D.; Gelder, C.; Glossop, A.; Church, A. C.; Creagh-Brown, J. W. D.; Felton, T.; Foëx, B.; Mansfield, L.; McDonnell, L.; Parker, R.; Patterson, C. M.; Sovani, M.; Thomas, L.. BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults. Thorax. 2016;71(Suppl 2), ii1-ii35. [Quality Measures,Clinical Practice Guidelines]
  • Davis, M. D.; Walsh, B. K.; Sittig, S. E.;Restrepo, R. D.. AARC clinical practice guideline: Blood gas analysis and hemoximetry. Respiratory Care. 2013;58(10), 1694-1703. [Quality Measures,Clinical Practice Guidelines]
  • De Rio-Pertuz, G.; Gutiérrez, J. F.; Triana, A. J.; Molinares, J. L.; Robledo-Solano, A. B.; Meza, J. L.; Ariza-Bolívar, O. M.; et al. Usefulness of sputum gram stain for etiologic diagnosis in community-acquired pneumonia: A systematic review and meta-analysis. BMC Infectious Diseases. 2019;19(1), 403. doi:10.1186/s12879-019-4048-6 Source[Metasynthesis,Meta-analysis,Systematic Review]
  • Doiron, K. A.; Hoffmann, T. C.; Beller, E. M. Early intervention (mobilization or active exercise) for critically ill adults in the intensive care unit. Cochrane Database of Systematic Reviews. 2018;(3) doi:10.1002/14651858.CD010754.pub2 [Metasynthesis,Meta-analysis,Systematic Review]
  • Epstein, E.; McDougall, M.; Thomas, P.. Intravenous fluids in hospital: Practical approaches. British Journal of Hospital Medicine. 2017;78(4), C50-C54. doi:10.12968/hmed.2017.78.4.C50 [Review Articles,Expert/Committee Opinion,Core Curriculum,Position Statements,Practice Bulletins]
  • Evans, L.; Rhodes, A.; Alhazzani, W.; Antonelli, M.; Coopersmith, C. M.; et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Intensive Care Medicine. 2021; doi:10.1007/s00134-021-06506-y Source[Clinical Practice Guidelines]
  • Ferreyro, B. L.; Angriman, F.; Munshi, L.; Del Sorbo, L.; Ferguson, N. D.; Rochwerg, B.; et al. Association of noninvasive oxygenation strategies with all-cause mortality in adults with acute hypoxemic respiratory failure: a systematic review and meta-analysis. JAMA. 2020;324(1), 57-67. doi:10.1001/jama.2020.9524 [Meta-analysis,Systematic Review]
  • Gulanick, M.; Myers, J. (2022). Nursing Care Plans: Diagnoses, Interventions, and Outcomes. St. Louis: Elsevier. [Core Curriculum]
  • Kalil, A. C.; Metersky, M. L.; Klompas, M.; Muscedere, J.; Sweeney, D. A.; Palmer, L. B.; Napolitano, L. M.; O'Grady, N. P.; Bartlett, J. G.; Carratalà, J.; El Solh, A. A.; Ewig, S.; Fey, P. D.; File Jr., T. M.; Restrepo, M. I.; Roberts, J. A.; Waterer, G. W.; Cruse, P.; Knight, S. L.; Brozek, J. L. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of america and the american thoracic society. Clinical Infectious Diseases. 2016;63(5), e61-e111. doi:10.1093/cid/ciw353 [Quality Measures,Clinical Practice Guidelines]
  • Lewis, L. K.; Williams, M. T.; Olds, T. S. The active cycle of breathing technique:  A systematic review and meta-analysis. Respiratory Medicine. 2012;106(2), 155-172. [Metasynthesis,Meta-analysis,Systematic Review]
  • MacDonald, N.; Pearse, R. M. Are we close to the ideal intravenous fluid?. British Journal of Anaesthesia. 2017;119, i63-i71. doi:10.1093/bja/aex293 Source[Review Articles,Expert/Committee Opinion,Core Curriculum,Position Statements,Practice Bulletins]
  • Malbrain, M. L.; Marik, P. E.; Witters, I.; Cordemans, C.; Kirkpatrick, A. W.; Roberts, D. J.; Van Regenmortel, N. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: A systematic review with suggestions for clinical practice. Anaesthesiology Intensive Therapy. 2014;46(5), 361-380. doi:10.5603/AIT.2014.0060 [Metasynthesis,Meta-analysis,Systematic Review]
  • Metlay, J. P.; Waterer, G. W.; Long, A. C.; Anzueto, A.; Brozek, J.; Crothers, K.; Cooley, L. A.; Dean, N. C.; Fine, M. J.; Flanders, S. A.; Griffin, M. R. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. American Journal of Respiratory and Critical Care Medicine. 2019;200(7), e45-e67. doi:10.1164/rccm.201908-1581ST Source[Quality Measures,Clinical Practice Guidelines]
  • Metlay, J. P.; Waterer, G. W.; Long, A. C.; Anzueto, A.; Brozek, J.; Crothers, K.; Cooley, L. A.; Dean, N. C.; Fine, M. J.; Flanders, S. A.; Griffin, M. R. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. American Journal of Respiratory and Critical Care Medicine. 2019;200(7), e45-e67. doi:10.1164/rccm.201908-1581ST Source[Quality Measures,Clinical Practice Guidelines]
  • Mitchell, B. G.; Russo, P. L.; Cheng, A. C.; Stewardson, A. J.; Rosebrock, H.; Curtis, S. J.; et al. Strategies to reduce non-ventilator-associated hospital-acquired pneumonia: A systematic review. Infection, Disease & Health. 2019; doi:10.1016/j.idh.2019.06.002 Source[Metasynthesis,Meta-analysis,Systematic Review]
  • National Institute for Health and Care Excellence (NICE). (2014). NICE quality standard:  Infection prevention and control. Manchester, England: National Institute for Health and Care Excellence (NICE). [Quality Measures,Clinical Practice Guidelines]
  • National Institute for Health and Care Excellence (NICE). (2019). Pneumonia (community acquired): antimicrobial prescribing [NG138]. Manchester, England: National Institute for Health and Care Excellence (NICE). Source[Quality Measures,Clinical Practice Guidelines]
  • National Institute for Health and Care Excellence (NICE). (2019). Pneumonia (community acquired): antimicrobial prescribing [NG138]. Manchester, England: National Institute for Health and Care Excellence (NICE). Source[Quality Measures,Clinical Practice Guidelines]
  • National Institute for Health and Care Excellence (NICE). (2019). Pneumonia (hospital-acquired): Antimicrobial prescribing. NICE guideline [NG139]. Manchester, England: National Institute for Health and Care Excellence (NICE). Source[Clinical Practice Guidelines]
  • National Institute for Health and Care Excellence (NICE). (2021). COVID-19 rapid guideline: managing COVID -19 [NG191]. Source[Quality Measures,Clinical Practice Guidelines]
  • National Institute for Health and Care Excellence. (2013 [Updated 2017]). Intravenous fluid therapy in adults in hospital . Source[Quality Measures,Clinical Practice Guidelines]
  • National Institute for Health and Care Excellence. (2016). Sepsis: Recognition, diagnosis and early management. (NICE guideline [NG51]). Source[Quality Measures,Clinical Practice Guidelines]
  • O'Driscoll, B. R.; Howard, L. S.; Earis, J.; Mak, V.; British Thoracic Society Emergency Oxygen Guideline Group. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017, Jun;72(Suppl 1), ii1-ii90. [Quality Measures,Clinical Practice Guidelines]
  • Rennert-May, E.; Chew, D. S.; Conly, J.; Guirguis, M.; Slobodan, J.; Fryters, S.; Bresee, L. Clinical practice guideline for creating an acute care hospital-based antimicrobial stewardship program: A systematic review. American Journal of Infection Control. 2019;47(8), 979-993. doi:10.1016/j.ajic.2019.02.010 Source[Systematic Review]
  • Rochwerg, B.; Brochard, L.; Elliott, M. W.; Hess, D.; Hill, N. S.; Nava, S.; Navalesi, P.; Antonelli, M.; Brozek, J.; Conti, G.; Ferrer, M.; Guntupalli, K.; Jaber, S.; Keenan, S.; Mancebo, J.; Mehta, S.; Raoof, S. Official ERS/ATS clinical practice guidelines: Noninvasive ventilation for acute respiratory failure. European Respiratory Journal. 2017;50(2) doi:10.1183/13993003.02426-2016 [Quality Measures,Clinical Practice Guidelines]
  • Rothrock, S. G.; Cassidy, D. D.; Barneck, M.; Schinkel, M.; Guetschow, B.; Myburgh, C.; Nguyen, L.; Earwood, R.; Nanayakkara, P. W. B.; Nannan Panday, R. S.; Briscoe, J. G. Outcome of Immediate Versus Early Antibiotics in Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis. Annals of Emergency Medicine. 2020, Oct;76(4), 427-441. doi:10.1016/j.annemergmed.2020.04.042 Source[Meta-analysis,Systematic Review]
  • Siegel, J. D.; Rhinehart, E.; Jackson, M.; Chiarello, L.; Healthcare Infection Control Practices Advisory Committee. Guideline for isolation precautions:  Preventing transmission of infectious agents in healthcare settings. American Journal of Infection Control. 2007, June;35, S64-S164. [Quality Measures,Clinical Practice Guidelines]
  • Siemieniuk, R. A.; Chu, D. K.; Kim L. H. Y.; Güell-Rous, M. R.; Alhazzani, W.; Soccal, P. M.; Karanicolas, P. J.; Farhournand, P. D.; Siemieniuk, J. L. K.; Satia, I.; Irusen, E. M.; Refaat, M. M.; Mikita, J. S.; Smith, M.; Cohen, D. N.; Vandvik, P. O.; Agoritsas, T.; Lytvyn, L.; Guyatt, G.. Oxygen therapy for acutely ill medical patients: A clinical practice guideline. BMJ. 2018;363, k4169. doi:10.1136/bmj.k4169 Source[Quality Measures,Clinical Practice Guidelines]
  • Stern, A.; Skalsky, K.; Avni, T.; Carrara, E.; Leibovici, L.; Paul, M. Corticosteroids for pneumonia. Cochrane Database of Systematic Reviews. 2017;(12) doi:10.1002/14651858.CD007720.pub3 [Metasynthesis,Meta-analysis,Systematic Review]
  • Stern, A.; Skalsky, K.; Avni, T.; Carrara, E.; Leibovici, L.; Paul, M. Corticosteroids for pneumonia. Cochrane Database of Systematic Reviews. 2017;(12) doi:10.1002/14651858.CD007720.pub3 [Metasynthesis,Meta-analysis,Systematic Review]
  • Strickland, S. L.; Rubin, B. K.; Drescher, G. S.; Haas, C. F.; O'Malley, C. A.; Volsko, T. A.; Branson, R. D.; Hess, D. R. AARC clinical practice guideline:  Effectiveness of nonpharmacologic airway clearance therapies in hospitalized patients. Respiratory Care. 2013;58(12), 2187-2193. doi:10.4187/respcare.02925 [Quality Measures,Clinical Practice Guidelines]
  • Strickland, S. L.; Rubin, B. K.; Haas, C. F.; Volsko, T. A.; Drescher, G. S.; O'Malley, C. A. AARC clinical practice guideline: Effectiveness of pharmacologic airway clearance therapies in hospitalized patients. Respiratory Care. 2015;60(7), 1071-1077. [Quality Measures,Clinical Practice Guidelines]
  • Tarrant, B. J.; Le Maitre, C.; Romero, L.; Steward, R.; Button, B. M.; Thompson, B. R.; Holland, A. E. Mucoactive agents for adults with acute lung conditions: A systematic review. Heart & Lung. 2019;48(2), 141-147. doi:10.1016/j.hrtlng.2018.09.010 Source[Systematic Review]
  • The Joint Commission. Approved: new antimicrobial stewardship standard. Joint Commission Perspectives. 2016;36(7), 1-8. [Regulatory/Accreditation Standards]
  • Ticona, J. H.; Zaccone, V. M.; McFarlane, I. M. Community-acquired pneumonia: a focused review. American Journal of Medical Case Reports. 2021;9(1), 45-52. doi:10.12691/ajmcr-9-1-12 [Review Articles,Expert/Committee Opinion]
  • Ticona, J. H.; Zaccone, V. M.; McFarlane, I. M. Community-acquired pneumonia: a focused review. American Journal of Medical Case Reports. 2021;9(1), 45-52. doi:10.12691/ajmcr-9-1-12 [Review Articles,Expert/Committee Opinion]
  • Ticona, J. H.; Zaccone, V. M.; McFarlane, I. M. Community-acquired pneumonia: a focused review. American Journal of Medical Case Reports. 2021;9(1), 45-52. doi:10.12691/ajmcr-9-1-12 [Review Articles,Expert/Committee Opinion]
  • Ticona, J. H.; Zaccone, V. M.; McFarlane, I. M. Community-acquired pneumonia: a focused review. American Journal of Medical Case Reports. 2021;9(1), 45-52. doi:10.12691/ajmcr-9-1-12 [Review Articles,Expert/Committee Opinion]
  • Torres, A.; Niederman, M. S.; Chastre, J.; et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia. European Respiratory Journal. 2017;50(3), 1-26. doi:10.1183/13993003.00582-2017 Source[Clinical Practice Guidelines]
  • Torres, A.; Niederman, M. S.; Chastre, J.; et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia. European Respiratory Journal. 2017;50(3), 1-26. doi:10.1183/13993003.00582-2017 Source[Clinical Practice Guidelines]
  • Torres, A.; Niederman, M. S.; Chastre, J.; et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia. European Respiratory Journal. 2017;50(3), 1-26. doi:10.1183/13993003.00582-2017 Source[Clinical Practice Guidelines]
  • Warnapura, C.; Peiris, M. Intravenous fluid therapy in adults and children. Sri Lankan Journal of Anaesthesiology. 2017;25(1) doi:10.4038/slja.v25i1.8202 [Review Articles,Expert/Committee Opinion,Core Curriculum,Position Statements,Practice Bulletins]
  • Zhang, L.; Hu, W.; Cai, Z.; Liu, J.; Wu, J.; Deng, Y.; Yu, K.; Chen, X.; Zhu, L.; Ma, J.; Qin, Y. Early mobilization of critically ill patients in the intensive care unit: A systematic review and meta-analysis. PLOS ONE. 2019;14(10), 1-16. doi:10.1371/journal.pone.0223185 [Meta-analysis,Systematic Review]

Disclaimer

Clinical Practice Guidelines represent a consistent/standardized approach to the care of patients with specific diagnoses. Care should always be individualized by adding patient specific information to the Plan of Care.

;